STAAR Surgical | STAA - Ebit

Aktienkurs
32.07
Täglich Wechseln
0.06 0.19%
Monatlich
30.26%
Jährlich
66.86%
Q2 Prognose
31.43




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Bausch Health Companies USD 489M 230M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Cerus USD -1.45M 488K 2024-12
Cooper Companies USD 212.8M 72.4M 2025-12
J&J USD 6.62B 1.51B 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Novartis USD 4.18B 118M 2026-03
OraSure Technologies USD -13.59M 2.13M 2025-12
Orthofix International USD 6.12M 1.91M 2025-12
STAAR Surgical USD 17.4M 28.34M 2026-03
Utah Medical Products USD 2.44M 2M 2025-12